We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA MAKES CHANGES TO ORPHAN DRUG FUNDING PROGRAM
FDA MAKES CHANGES TO ORPHAN DRUG FUNDING PROGRAM
January 13, 2005
The FDA’s funding program for clinical trials investigating orphan drugs will undergo some changes in fiscal 2006, including alterations to the way funding limitations are established, according to a Jan. 13 notice released by the agency.